StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) income statement

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$156.23−1.49 (-0.94%)

Close on Nov 18, 2026Market cap $6.15BP/E –Yield –

Belite Bio, Inc income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-16.9%

Financial strength

Current ratio
50.02
Debt to equity
–
Debt to assets
–
Cash to current liabilities
3571.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
7.98
Dividend yield
–

See a number that looks wrong?